Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Outbreak ofTinea capitis caused by Microsporum ferrugineum in Thailand

  • 32 Accesses

  • 5 Citations

Abstract

There was an outbreak ofTinea capitis at the Pak-kred Home for Mentally and Physically Handicapped Babies, Bangkok, Thailand in 1993. One hundred and thirty-eight cases were diagnosed as tinea capitis based on clinical signs and positive laboratory investigations. The results of Wood's light examination, KOH preparation and fungal culture were positive in 89.9, 75.9 and 27.4% respectively. The non-inflammatory form had a higher rate of positive KOH and culture than in the inflammatory form.Microsporum ferrugineum was the major pathogen (66.7%) and most of its infections (80.4%) caused a non-inflammatory type of tinea capitis. Griseofulvin, in a dosage of 10–15 mg/kg/day and selenium sulfide shampoos, yielded an 84.8% cure rate within 14.9 weeks. No recurrence or obvious adverse reactions were observed.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Wisuthsarewong W, Kullavanijaya P, Viravan S. Superficial fungal infections in Thai children. Thai J Pediatr 1995; 36: 230–8.

  2. 2.

    Krowchuk DP, Lucky AW, Primmer SI, McGuire J. Current status of the identification and management of tinea capitis. Pediatrics 1983; 72: 625–31.

  3. 3.

    Kotrajaras R, Chongsathien S, Rojanavanich V. Fungal infection in children in Thailand. 4th International Congress of Pediatric Dermatology Edited by Urabe K, Kimura M, Yamamoto K, Ogawa H. 1987: pp.197–203.

  4. 4.

    Laude TA, Shah BR, Lynfield Y. Tinea capitis in Brooklyn. Am J Dis Child 1982; 136: 1047–50.

  5. 5.

    Sehgal VN, Saxena AK, Kumari S. Tinea capitis: A clinicoetiologic correlation. Int J Dermatol 1985; 24: 116–9.

  6. 6.

    Venugopal PV, Venugopal T. Tinea capitis in Saudi Arabia. Int J Dermatol 1993; 32: 39–40.

  7. 7.

    Ginsburg CM. Superficial fungal and mycobacterial infections of the skin. Pediatr Infect Dis J 1985; 4: S19–23.

  8. 8.

    Hubbard TW, Triquet JM. Brush-culture method for diagnosing tinea capitis. Pediatrics 1992; 90: 416–8.

  9. 9.

    Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: Should ketoconazole replace griseofulvin? J Pediatr 1988; 112: 987–91.

  10. 10.

    Gan VN, Petruska M, Ginsburg C. Epidemiology and treatment of tinea capitis: ketoconazole vs griseofulvin. Pediatr Infect Dis J 1987; 6: 46–9.

  11. 11.

    Rudolph AH. The diagnosis and treatment of tinea capitis due toTrichophyton tonsurans. Int J Dermatol 1985; 24: 426–31.

  12. 12.

    Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: Adjunctive therapy for tinea capitis. Pediatrics 1982; 69: 81–3.

  13. 13.

    Odom R. Pathophysiology of dermatophyte infections. J Am Acad Dermatol 1993; 28: S2–7.

  14. 14.

    Lukacs A, Korting HC, Lindner A. Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses 1994; 37: 451–3.

  15. 15.

    Legendre R, Steltz M. A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes. Rev Infect Dis 1980; 2: 586–91.

  16. 16.

    Martinez-Roig A, Torres-Rodriguez JM, Bartlett-Coma A. Double-blind study of ketoconazole and griseofulvin in dermatophytoses. Pediatr Infect Dis J 1988; 7: 37–40.

  17. 17.

    Ginsburg CM, McCracken GH, Olsen K. Pharmacology of ketoconazole suspension in infants and children. Antimicrob Agents Chemother 1983; 23: 787–9.

  18. 18.

    Elewski BE, Tinea capitis: Itraconazole inTrichophyton tonsurans infection. J Am Acad Dermatol 1994; 31: 65–7.

  19. 19.

    Lopez-Gomez S, Palacio A, Cutsem JV, et al. Itraconazole versus griseofulvin in the treatment of tinea capitis: A doubleblind randomized study in children. Int J Dermatol 1994; 33: 743–7.

  20. 20.

    Jones TC. Overview of the use of terbinafine (Lamisil®) in children. Br J Dermatol 1995; 132: 683–9.

  21. 21.

    Nejjam F, Zagula M, Cabiac MD, Guessous N, Humbert H, Lakhdar H. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995; 132: 98–105.

  22. 22.

    Ajao AO, Akintunde C. Studies on the prevalence of tinea capitis infection in Ile-Ife, Nigeria. Mycopathologia 1985; 89: 43–8.

  23. 23.

    Schwinn A, Ebert J, Muller I, Brocker EB.Trichophyton rubrum as the causative agent of tinea capitis in three children. Mycoses 1995; 38: 9–11.

  24. 24.

    Snowden MS, Loder L, Alexander WJ. Infectious alopecia in a child day-care center. JAMA 1985; 254: 3038.

  25. 25.

    Hebert AA, Head ES, MacDonald EM. Tinea capitis caused byTrichophyton tonsurans. Pediatr Dermatol 1985; 2: 219–23.

  26. 26.

    Vargo K, Cohen BA. Prevalence of undetected tinea capitis in household members of children with disease. Pediatrics 1993; 92: 155–7.

  27. 27.

    Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics 1995; 96: 265–7.

  28. 28.

    Shtayeh MS, Arda HM. Incidence of dermatophytosis in Jordan with special reference to tinea capitis. Mycopathologia 1985; 92: 59–62.

Download references

Author information

Correspondence to Suchitra Viravan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wisuthsarewong, W., Chaiprasert, A. & Viravan, S. Outbreak ofTinea capitis caused by Microsporum ferrugineum in Thailand. Mycopathologia 135, 157–161 (1996). https://doi.org/10.1007/BF00632337

Download citation

Key words

  • diagnosis
  • Microsporum ferrugineum
  • tinea capitis
  • treatment